Vaccination against Rotavirus Infections
Authors:
H. Ambrožová
Authors‘ workplace:
1. infekční klinika UK 2. LF a FN Na Bulovce, Praha
Published in:
Čes-slov Pediat 2008; 63 (10): 594-598.
Category:
Actual Topic
Sources
1. Van Damme P. Evidence – based recommendation for the use of rotavirus vaccines in Europe. 25th Annual Meeting of the European Society for Pediatric Infectious Diseases, Porto, May 2–4, 2007. Book of Abstracts, str. 3.
2. Vesicari T, Van Damme P, Giaquinto C, et al. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology and Nutrition Evidence – based recommendations for rotavirus vaccination in Europe. J. Ped. Gast. Nutr. 2008;166(Suppl 2): S38–S48.
3. Giaquinto C, Van Damme P, Huet F, et al. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004–2005: The REVEAL Study. J. Infect. Dis. 2007;195: S26–S35.
4. Montse Soriano-Gabarró, Mrukowicz J, et al. Burden of rotavirus disease in European Union countries. Ped. Infect. Dis. J. 2006;25: S7–11.
5. Van Damme P, Giaquinto C, Huet F, et al. Multicenter prospective study of the burden of rotavirus acute gastroentreritis in Europe, 2004–2005: The REVEAL Study. J. Infect. Dis. 2007;195(Suppl 1): S4–S16.
6. Giaquinto C, Van Damme P, Huet F, et al. Costs of community – acquired pediatric rotavirus gastroenteritis in 7 European countries: The REVEAL Study. J. Infect. Dis. 2007;195(Suppl 1): S36–S44.
7. EPIDAT 2007. Praha: CME SZÚ.
8. Glezies O, Desselberger U, Tatochenko V, et al. Nosocomial rotavirus infection in European countries. A review of the epidemiology, severity and economic burden of hospital acquired rotavirus diseases. Ped. Infect. Dis. J. 2006;25: S12–21.
9. Richardson S, Grimwood K. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998;351: 1844–1888.
10. Vesikari T, Giaquinto C, Huppertz H. Clinical trials of rotavirus vaccines in Europe. Ped. Infect. Dis. J. 2006;25: S42–S47.
11. Souhrn údajů o přípravku, SPC Rotarix, datum revize textu 21. 2. 2006.
12. Goveia NM, Rodriguez ZM, Dallas MJ, et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Ped. Inf. Dis. J. 2007;12: 1099–1104.
13. Vesikari T, Mason DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl. J. Med. 2006;354: 23–33.
14. Souhrn údajů o přípravku, SC Rota Teq, datum revize textu 24. 7. 2007.
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2008 Issue 10
Most read in this issue
- Henoch-Schönlein Purpura from the Standpoint of Preventive Corticoid Administration
- Assessment of Clinical Signs of Intracranial Hypertension in Newborns and Infants with Hydrocephalus in Relationship to the Indication of Drainage Procedure
- Prader-Willi Syndrome in Newborns – Two Case Reports
- Heterotopy of Stomach Mucosa – Review of Literature and Our Experience